Jenner & Block advised Merge Healthcare Inc. (NASDAQ: MRGE) in its $1 billion sale to IBM (NYSE: IBM). Merge is a Chicago-based provider of medical image handling and processing, interoperability and clinical systems designed to advance healthcare quality and efficiency. Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion. The closing of the transaction is subject to regulatory review, Merge shareholder approval, and other customary closing conditions, and is expected to occur later this year.
The full release is available here.
The Jenner & Block team was led by Partner Mark A. Harris, chair of the firm’s Private Equity Practice, and included Corporate Partners Brian R. Boch, Jeffrey R. Shuman and Jeffery D. Larson; Special Counsel Matthew R. Pacella; and Associates Kevin M. Waklatsi and Brendan A. Donahue. Other members of the multidisciplinary team included Partner Howard S. Suskin from the Litigation Department; Carla J. Rozycki, chair of the firm’s Labor and Employment Practice; Partner Adam Petravicius, chair of the Intellectual Property Transactions Practice; Partner Geoffrey M. Davis, co-chair of the Tax Practice; Partner S. Tony Ling, employment benefits and executive compensation; Partner Damien C. Specht, co-chair of the Government Contracts Corporate Transactions Group; and Associate Penelope P. Campbell in real estate.